SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (9758)5/2/1999 7:27:00 PM
From: aknahow  Respond to of 17367
 
Xoma already has 800. just about on schedule. Not hyperbolic growth. DSMB to meet soon. Doubt early halt will occur, but would be happy if it did. Remember there is no required mortality in this trial.

Robert K. please consider voting against management. While you might think it will do no good, there is a chance that it will.



To: Robert K. who wrote (9758)5/2/1999 7:44:00 PM
From: aknahow  Respond to of 17367
 
K 1 ( Actually K I) research. Many of wondered what you do when not posting. I found your site and published research.

ncbi.nlm.nih.gov

This is just one item that comes from your institute.

kib.ki.se

Klimchack in Swedish is Karolinska, or at least I have been assured this is the case by sources deep with XOMA. And of course XOMA always tells us the exact truth.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News